Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
Stock Snapshot
Incyte(INCY) stock is priced at $96.57, giving the company a market capitalization of 18.96B. It carries a P/E multiple of 16.01.
As of 2025-12-16, Incyte(INCY) stock has fluctuated between $96.44 and $98.69. The current price stands at $96.57, placing the stock +0.1% above today's low and -2.1% off the high.
Incyte(INCY) shares are trading with a volume of 641.68K, against a daily average of 2.39M.
In the last year, Incyte(INCY) shares hit a 52-week high of $109.28 and a 52-week low of $53.56.
In the last year, Incyte(INCY) shares hit a 52-week high of $109.28 and a 52-week low of $53.56.
INCY News
Analyst Judah Frommer from Morgan Stanley maintained a Hold rating on Incyte and keeping the price target at $92.00. Claim 50% Off TipRanks Premium and Invest w...
Incyte (INCY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and...
New insider activity at Incyte ( (INCY) ) has taken place on December 12, 2025. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund leve...
Analyst ratings
46%
of 28 ratingsMore INCY News
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
In early December 2025, Incyte reported that its mutant calreticulin-targeted antibody INCA033989 received FDA Breakthrough Therapy designation for certain esse...
